14-day Premium Trial Subscription Try For FreeTry Free

Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 20 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ONPH
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Big movements in Oncology Pharma stock price on Thursday moving 9,900.00% between high and low
(Updated on Apr 25, 2024)

Sell candidate since Apr 25, 2024 PDF

The Oncology Pharma stock price gained 900.00% on the last trading day (Thursday, 25th Apr 2024), rising from $0.000001 to $0.00001. During the last trading day the stock fluctuated 9,900.00% from a day low at $0.000001 to a day high of $0.0001. The price has been going up and down for this period, and there has been a -90% loss for the last 2 weeks. Volume fell on the last day by -5 thousand shares and in total, 1 thousand shares were bought and sold for approximately $0.0129 . You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $0.00000657 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 47.51% during the next 3 months and, with a 90% probability hold a price between $0.00000969 and $0.0016 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ONPH Signals & Forecast

There are few to no technical positive signals at the moment. The Oncology Pharma stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $0.0004 and $0.0002. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, April 08, 2024, and so far it has fallen -99.00%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Oncology Pharma stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.000099 between high and low, or 9,900.00%. For the last week the stock has had daily average volatility of 41,960.00%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ONPH) For The Upcoming Trading Day Of Friday 26th

For the upcoming trading day on Friday, 26th we expect Oncology Pharma Inc. to open at $0.000037, and during the day (based on 14 day Average True Range), to move between -$0.0054 and $0.0054, which gives a possible trading interval of +/-$0.0054 (+/-53 667.59%) up or down from last closing price. If Oncology Pharma Inc. takes out the full calculated possible swing range there will be an estimated 107 335.18% move between the lowest and the highest trading price during the day.

Is Oncology Pharma Inc. stock A Buy?

The Oncology Pharma stock holds several negative signals and despite the positive trend, we believe Oncology Pharma will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

Current score: -4.314 Sell Candidate Downgraded

Predicted Opening Price for Oncology Pharma Inc. of Friday, April 26, 2024

Fair opening price April 26, 2024 Current price
$0.000037 ( 270.00%) $0.00001

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ONPH

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.0001 1,260.00 %
R2 0.00009818 881.82 %
R1 0.00007482 648.18 %
Current price: 0.00001
Support S1 -0.00000082 -108.18 %
S2 -0.00002418 -341.82 %
S3 -0.000062 -720.00 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 0 .
Current price 0.00001
Support S1 0 .
S2 0 .
S3 0 .

FAQ

What is the symbol for Oncology Pharma Stock and on which exchange is it traded?
The symbol for Oncology Pharma is ONPH and it is traded on the PINK (Pink Sheets).

Should I buy or sell Oncology Pharma Stock?
The Oncology Pharma stock holds several negative signals and despite the positive trend, we believe Oncology Pharma will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

How to buy Oncology Pharma Stock?
Oncology Pharma Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Oncology Pharma Stock.

What's the current price of Oncology Pharma Stock?
As of the end of day on the Apr 25, 2024, the price of an Oncology Pharma (ONPH) share was $0.00001.

What is the 52-week high and low for Oncology Pharma Stock?
The 52-week high for Oncology Pharma Stock is $1.05 and the 52-week low is $0.000001.

What is the market capitalization of Oncology Pharma Stock?
As of the Apr 25, 2024, the market capitalization of Oncology Pharma is 27.
Click to get the best stock tips daily for free!

About Oncology Pharma Inc.

Oncology Pharma Inc., an oncology company, develops, manufactures, and commercializes therapeutics. The company has a collaboration and licensing agreement with Kalos Therapeutics Inc. for exploring treatment opportunities of the COVID-19 virus. The company was formerly known as SourcingLink.net Inc. and changed its name to Oncology Pharma Inc. in June 2019. Oncology Pharma Inc. was incorporated in 1993 and is based in San Francisco, California.... ONPH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT